Updated Jul 16, 2026
DiFabio Andrea is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $231K.

Andrea Difabio is the Chief Legal Officer of Xenon Pharmaceuticals Inc., as disclosed in the SEC filing dated 2026-01-09 (CIK 0001692506). In this role, she leads Xenon's legal affairs, corporate governance, intellectual property strategy, and compliance for its neuroscience-focused biopharmaceutical programs.
| Role | Insider |
|---|---|
| Notability | 40/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-14 | XENE | Xenon Pharmaceuticals Inc. | S — Open-market sale [10b5-1] | 1.3K | $55.23 | $74K |
| 2026-03-14 | XENE | Xenon Pharmaceuticals Inc. | M — Option exercise [10b5-1] | 3.8K | — | |
| 2026-03-11 | XENE | Xenon Pharmaceuticals Inc. | S — Open-market sale [10b5-1] | 2.6K | $60.11 | $157K |
| 2026-03-11 | XENE | Xenon Pharmaceuticals Inc. | M — Option exercise [10b5-1] | 7.5K | — |
Andrea Difabio is the Chief Legal Officer of Xenon Pharmaceuticals Inc., as disclosed in the SEC filing dated 2026-01-09 (CIK 0001692506). In this role, she leads Xenon's legal affairs, corporate governance, intellectual property strategy, and compliance for its neuroscience-focused biopharmaceutical programs.…
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($231K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live DiFabio Andrea profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.